Lucas GC Ltd current report, Q4 FY2026

Business context and reporting period

Lucas GC Limited filed this Form 6-K for October 2026. It reports shareholder actions approved at an extraordinary general meeting on October 2, 2026, including a share capital restructuring and adoption of amended and restated memorandum and articles of association (M&AA).

Key financial and capital information

The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics.

  • Authorized share capital remains US$500,000, but the authorized share count changes from 20,000,000 shares with a par value of US$0.025 each to 50,000,000,000 shares with a par value of US$0.00001 each.
  • The new authorized capital comprises 49.5 billion Class A ordinary shares and 500 million Class B ordinary shares.
  • The filing does not state the resulting issued and outstanding share count or provide a clear conversion ratio for shareholders’ existing shares.

Material changes versus the prior position

  • The company effected the approved share capital restructuring and replaced its prior M&AA with amended and restated articles.
  • The M&AA changes the deemed delivery period for notices sent by post from five to three calendar days. This amendment took effect immediately following the EGM.
  • The company anticipated that the restructuring would be reflected by Nasdaq and in the marketplace beginning with trading on October 7, 2026.

Outlook, risks, and unusual items

The filing provides no financial guidance or operating outlook. The Nasdaq reflection date is stated as an anticipation, not a reported confirmation. The report and referenced exhibits are incorporated by reference into the company’s specified Form F-3 and Form S-8 registration statements, subject to later filings or reports.

The text contains an exhibit-reference inconsistency: it refers to attached Exhibits 99.1 and 99.2, while the exhibit index lists Exhibit 3.1 as the amended and restated M&AA.

Important facts for investors to verify

  • Confirm the final effective date and Nasdaq treatment of the restructuring.
  • Review the actual issued and outstanding share counts and how existing shares are treated; these details are not clear in the filing text.
  • Check the filed M&AA and reconcile the exhibit references against the complete filing.